Schizophrenia and Schizoaffective Disorder Clinical Trial
Official title:
A Prospective Open-Label Study of Aripiprazole in the Management of Patients With Schizophrenia in General Psychiatric Practices
The purpose of this clinical research study is to evaluate the overall effectiveness of 8 week of aripiprazole treatment.
n/a
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT01804920 -
D-Serine Treatment For Tardive Dyskinesia
|
N/A | |
Completed |
NCT00347425 -
Switch Study of Existing Atypical Antipsychotics to Bifeprunox
|
Phase 3 |